Fulgent Genetics (FLGT) Income from Non-Controlling Interests (2021 - 2026)
Fulgent Genetics' (FLGT) quarterly Income from Non-Controlling Interests came in at -$189000.0 in Q2 2026, up 36.79% year-over-year from -$138168.7 in Q2 2025, and up 57.81% quarter-over-quarter from -$448000.0 in Q1 2026.
Powered by 
Analysis
Fulgent Genetics (FLGT) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
Fulgent Genetics has disclosed Income from Non-Controlling Interests across 6 years of filings, most recently posting -$189000.0 for Q2 2026.
- In Q2 2026, Income from Non-Controlling Interests rose 36.79% year-over-year to -$189000.0; the TTM figure through Jun 2026 stood at $3.5 million (up 444.09% YoY), while the FY2025 annual figure was $3.5 million, up 411.6% from the prior year.
- Income from Non-Controlling Interests came in at -$189000.0 for Q2 2026 at Fulgent Genetics, up from -$448000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $4.4 million in Q4 2025 to a low of -$6.2 million in Q4 2023.
- Average Income from Non-Controlling Interests over 5 years is -$398777.8, with a median of -$365000.0 recorded in 2023.
- Year-over-year, Income from Non-Controlling Interests slumped 2434.84% in 2023 and soared 1540.73% in 2025.
- Over 5 years, Income from Non-Controlling Interests stood at -$244000.0 in 2022, then tumbled by 2434.84% to -$6.2 million in 2023, then surged by 95.12% to -$302000.0 in 2024, then soared by 1540.73% to $4.4 million in 2025, then slumped by 104.34% to -$189000.0 in 2026.
- Per Business Quant data, the three most recent Income from Non-Controlling Interests figures were -$189000.0 in Q2 2026, -$448000.0 in Q1 2026, and $4.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 14.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 400,000.00 |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -153,000.00 |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn | -189,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -189,000.00 |
| Mar 31, 2026 | -448,000.00 |
| Dec 31, 2025 | 4.35 Mn |
| Sep 30, 2025 | -218,000.00 |
| Jun 30, 2025 | -299,000.00 |
| Mar 31, 2025 | -369,000.00 |
| Dec 31, 2024 | -302,000.00 |
| Sep 30, 2024 | -46,000.00 |
| Jun 30, 2024 | -380,000.00 |
| Mar 31, 2024 | -384,000.00 |
| Dec 31, 2023 | -6.19 Mn |
| Sep 30, 2023 | -359,000.00 |
| Jun 30, 2023 | -361,000.00 |
| Mar 31, 2023 | -509,000.00 |
| Dec 31, 2022 | -244,000.00 |
| Sep 30, 2022 | -376,000.00 |
| Jun 30, 2022 | -438,000.00 |
| Mar 31, 2022 | -422,000.00 |
| Dec 31, 2021 | -662,000.00 |
| Sep 30, 2021 | -298,000.00 |